Corindus Vascular Robotics Inc

Corindus Vascular Robotics — Investor Presentation (January 2018)

13 slides from Corindus Vascular Robotics's investor presentation, Jan 8, 2018

  1. Slide 1: Precision Vascular Robotics

    1 Precision Vascular Robotics Corindus Vascular Robotics (CVRS) January 2018

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements This presentation contains “forward - looking statements” (as such term is defined in Section 27 A of the Securities Act of 1933 , as amended, and Section 21 E of the Securities Exchange Act of 1934 , as amended), and information relating to the company, that are based on

  3. Slide 3: Corindus Today: A leader in vascular robotics

    Corindus Today A leader in vascular robotics LARGE Market Opportunity with Long GROWTH Runway $4.5B 1 market opportunity in 2018 driven by over 2.5 million coronary and 3 million non - coronary procedures performed per year DIFFERENTIATED Technology ONLY FDA cleared robotic platform for percutaneous

  4. Slide 4: Interventional Market Opportunity

    1 Market opportunity assessment based on market research reports and Corindus estimate 2 Peripheral Vascular includes lower limb, carotid, renal, iliac and AAA (abdominal aortic aneurysm) procedures 3 Millennium Research Group Interventional Market Opportunity Large & growing worldwide market • $4.5

  5. Slide 5: Company Milestones

    Company Milestones 5 Next Generation CorPath GRX cleared by FDA with Guide Catheter Control and Enhanced User Interface CorPath GRX seeing high utilization in cath labs & 2x increase in adoption with existing customers Adoption Global Signed Distribution Agreement with 2 nd largest company in Japan

  6. Slide 6: Robotics in the Cath Lab

    Robotics in the Cath Lab 6 Second Generation Robotic - assisted PCI System BEDSIDE UNIT • Optimized bedside unit for radial access • Simple setup & in - procedure workflow • Devices fixed during intervention • Imaging and device agnostic INTERVENTIONAL COCKPIT • Precise robotic control of x Guide ca

  7. Slide 7: Traditional PCI vs Robotic PCI

    Struggle to see angiography Close proximity ergonomic visualization Trial & error, wire spinning Precise ‘Point & Shoot’ predictability ‘Eyeball’ estimate Robotic - assisted sub - mm Measurement Manual adjustment 1mm precise positioning Devices loose during inflation Fixated devices during deploymen

  8. Slide 8: Why Vascular Robotics

    Why Vascular Robotics 8 Benefits for patients, physicians, & hospitals DIFFERENTIATION • Position hospital on the cutting edge by deploying robotics as part of a hi - tech cardiology model • Clinical leadership • Attract & retain physicians PATIENT BENEFIT • Robotic precision reduces stent utilizati

  9. Slide 9: Evolution of Interventional Treatment

    Evolution of Interventional Treatment 9 Hi - tech cardiology model with robotics Occupational Hazards High risk working environment Physician burnout Traditional PCI Stagnant Market Competition for market share Radial adoption slow Precise Treatment Precise robotic movement Enhanced visualization Mu

  10. Slide 10: Vascular Robotic Clinical Roadmap

    Vascular Robotic Clinical Roadmap Demonstrating excellence in multiple lesion types and anatomies Product Evolution Robotic system capability Exploratory Feasibility Expand Use NEURO PERIPHERAL PCI 10 CorPath 200 and CorPath GRX Systems are indicated for PCI. Only the CorPath 200 System is indicated

  11. Slide 11: Clinical Leadership

    Clinical Leadership 11 J. Aaron Grantham, MD Saint Luke's Hospital of Kansas City Marty Leon, MD NewYork - Presbyterian Hospital Louis Cannon, MD BioStar Ventures Campbell Rogers, MD HeartFlow Steven Almany, MD Beaumont Hospital David Kandzari, MD Piedmont Heart Bill Lombardi, MD University of Washi

  12. Slide 12: Catalysts & Strategic Objectives

    12 Catalysts & Strategic Objectives Software Enhancements 1st Automated Movement Expanding Indications Peripheral Japan Commercial Launch Remote Capabilities Telestenting China Planned Expansion 2018 2019 - 2020 2021 - 2023 FOUNDATION : THREE PILLARS OF GROWTH Technology Development Market Expansion

  13. Slide 13: About Corindus Vascular Robotics

    Corindus Vascular Robotics, Inc. is a global technology leader in robotic - assisted vascular interventions. The company's CorPath ® System is the first FDA - cleared medical device to bring robotic - assisted precision to percutaneous coronary interventions. With the CorPath System, Corindus Vascul

Corindus Vascular Robotics — Investor Presentation (January 2018) on 6ix